UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies

Journal of psychiatric research, 2015-09, Vol.68, p.316-328

2015

Volltextzugriff (PDF)

The role of mTOR in depression and antidepressant responses

Life sciences (1973), 2014-04, Vol.101 (1-2), p.10-14

2014

Volltextzugriff (PDF)

The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research

Progress in neuro-psychopharmacology & biological psychiatry, 2019-08, Vol.94, p.109668-109668, Article 109668

2019

Volltextzugriff (PDF)

New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs

British journal of clinical pharmacology, 2016-11, Vol.82 (5), p.1280-1290

2016

Volltextzugriff (PDF)

Physical Exercise and Neuroinflammation in Major Depressive Disorder

Molecular neurobiology, 2019-12, Vol.56 (12), p.8323-8335

2019

Volltextzugriff (PDF)

Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities

Neuroscience and biobehavioral reviews, 2023-12, Vol.155, p.105425-105425, Article 105425

2023

Volltextzugriff (PDF)

The role of memantine in the treatment of major depressive disorder: Clinical efficacy and mechanisms of action

European journal of pharmacology, 2018-05, Vol.827, p.103-111

2018

Volltextzugriff (PDF)

Effects of chronic mild stress on the oxidative parameters in the rat brain

Neurochemistry international, 2009-05, Vol.54 (5), p.358-362

2009

Volltextzugriff (PDF)

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus

Progress in neuro-psychopharmacology & biological psychiatry, 2008, Vol.32 (1), p.140-144

2008

Volltextzugriff (PDF)

Maternal deprivation increases microglial activation and neuroinflammatory markers in the prefrontal cortex and hippocampus of infant rats

Journal of psychiatric research, 2019-08, Vol.115, p.13-20

2019

Volltextzugriff (PDF)

Pre- and Post-Synaptic protein in the major depressive Disorder: From neurobiology to therapeutic targets

Neuroscience, 2024-09, Vol.556, p.14-24

2024

Volltextzugriff (PDF)

Animal models as tools to study the pathophysiology of depression

Revista brasileira de psiquiatria, 2013, Vol.35 Suppl 2 (suppl 2), p.S112-S120

2013

Volltextzugriff (PDF)

Effect of co-administration of memantine and sertraline on the antidepressant-like activity and brain-derived neurotrophic factor (BDNF) levels in the rat brain

Brain research bulletin, 2017-01, Vol.128, p.29-33

2017

Volltextzugriff (PDF)

Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain

Behavioural brain research, 2011-08, Vol.221 (1), p.166-171

2011

Volltextzugriff (PDF)

Neurochemical correlation between major depressive disorder and neurodegenerative diseases

Life sciences (1973), 2016-08, Vol.158, p.121-129

2016

Volltextzugriff (PDF)

Relationship of Oxidative Stress as a Link between Diabetes Mellitus and Major Depressive Disorder

Oxidative medicine and cellular longevity, 2019-01, Vol.2019 (2019), p.1-6

2019

Volltextzugriff (PDF)

Resilience Dysregulation in Major Depressive Disorder: Focus on Glutamatergic Imbalance and Microglial Activation

Current neuropharmacology, 2018-03, Vol.16 (3), p.297-307

2018

Volltextzugriff (PDF)

A single dose of S‐ketamine induces long‐term antidepressant effects and decreases oxidative stress in adulthood rats following maternal deprivation

Developmental neurobiology (Hoboken, N.J.), 2015-11, Vol.75 (11), p.1268-1281

2015

Volltextzugriff (PDF)

Early Maternal Deprivation Induces Microglial Activation, Alters Glial Fibrillary Acidic Protein Immunoreactivity and Indoleamine 2,3-Dioxygenase during the Development of Offspring Rats

Molecular neurobiology, 2019-02, Vol.56 (2), p.1096-1108

2019

Volltextzugriff (PDF)

The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature

Frontiers in cellular and infection microbiology, 2022-12, Vol.12, p.983089

2022

Volltextzugriff (PDF)

Ketamine and imipramine in the nucleus accumbens regulate histone deacetylation induced by maternal deprivation and are critical for associated behaviors

Behavioural brain research, 2013-11, Vol.256, p.451-456

2013

Volltextzugriff (PDF)

Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats

Progress in neuro-psychopharmacology & biological psychiatry, 2009-04, Vol.33 (3), p.450-455

2009

Volltextzugriff (PDF)

Neonatal Immune Challenge with Lipopolysaccharide Triggers Long-lasting Sex- and Age-related Behavioral and Immune/Neurotrophic Alterations in Mice: Relevance to Autism Spectrum Disorders

Molecular neurobiology, 2018-05, Vol.55 (5), p.3775-3788

2018

Volltextzugriff (PDF)

Early life experience contributes to the developmental programming of depressive-like behaviour, neuroinflammation and oxidative stress

Journal of psychiatric research, 2017-12, Vol.95, p.196-207

2017

Volltextzugriff (PDF)

MAPK signaling correlates with the antidepressant effects of ketamine

Journal of psychiatric research, 2014-08, Vol.55, p.15-21

2014

Volltextzugriff (PDF)

1 – 25 von 126

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)

Publikationsform

Artikel
(122)
Buchkapitel
(4)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies

The role of mTOR in depression and antidepressant responses

The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research

New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs

Physical Exercise and Neuroinflammation in Major Depressive Disorder

Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities

The role of memantine in the treatment of major depressive disorder: Clinical efficacy and mechanisms of action

Effects of chronic mild stress on the oxidative parameters in the rat brain

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus

Maternal deprivation increases microglial activation and neuroinflammatory markers in the prefrontal cortex and hippocampus of infant rats

Pre- and Post-Synaptic protein in the major depressive Disorder: From neurobiology to therapeutic targets

Animal models as tools to study the pathophysiology of depression

Effect of co-administration of memantine and sertraline on the antidepressant-like activity and brain-derived neurotrophic factor (BDNF) levels in the rat brain

Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain

Neurochemical correlation between major depressive disorder and neurodegenerative diseases

Relationship of Oxidative Stress as a Link between Diabetes Mellitus and Major Depressive Disorder

Resilience Dysregulation in Major Depressive Disorder: Focus on Glutamatergic Imbalance and Microglial Activation

A single dose of S‐ketamine induces long‐term antidepressant effects and decreases oxidative stress in adulthood rats following maternal deprivation

Early Maternal Deprivation Induces Microglial Activation, Alters Glial Fibrillary Acidic Protein Immunoreactivity and Indoleamine 2,3-Dioxygenase during the Development of Offspring Rats

The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature

Ketamine and imipramine in the nucleus accumbens regulate histone deacetylation induced by maternal deprivation and are critical for associated behaviors

Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats

Neonatal Immune Challenge with Lipopolysaccharide Triggers Long-lasting Sex- and Age-related Behavioral and Immune/Neurotrophic Alterations in Mice: Relevance to Autism Spectrum Disorders

Early life experience contributes to the developmental programming of depressive-like behaviour, neuroinflammation and oxidative stress

MAPK signaling correlates with the antidepressant effects of ketamine

Aktive Filter

Suchergebnisse filtern